RBM10 and metastatic neoplasm: In addition, in BRCA, COAD, TGCT, KIRC, LIHC, lung cancer, ESCA, OV, and SKCM, the expression of RBM10 in metastatic tumor tissues was markedly increased in comparison with that in the corresponding primary tumor tissues (Figure 1(c)).